ChemBioChem
10.1002/cbic.201700634
FULL PAPER
were allowed. The following modifications were set as variable
modifications: carbamidomethyl (C), carbamyl (K), carbamyl (N-term),
Acknowledgements
deamidated (NQ), oxidation (M), and ε-azido-modified lysine (N
with 26 Da mass increment. The mass tolerance of parent ion was set as
20 ppm, and ±0.6 Da was set for the fragment ion. The fragment ions of
3
-Lys)
This work was supported by research grants (MOST 103-2113-
M-002-017-MY3) from the Ministry of Science and Technology
(Taiwan) and Chang Gung Medical Research Project
±
target peptides containing ε-azido lysine residues were manually verified.
(
CMRPG3F114). We thank Ms. Ya-Yun Yang and Ms. Ching-
Label-Free Quantitation. The label-free quantitation was processed with
Skyline (version 3.6.0.10162, MacCoss Lab, University of Washington,
USA) for estimation of relative abundance of distinct azido-modified Lys
residues between SSM and NSM groups. The Skyline spectral libraries
were created from Mascot search results. The raw files acquired from the
Orbitrap Elite mass spectrometer were processed with the workflow of
data-independent acquisition (DIA) with data-dependent acquisition (DDA)
spectral library to produce the MS1 chromatograms. MS1 peak
integration of targeted peptides containing azido-modified Lys residues
was visually inspected with the matched MS2 libraries and manually
adjusted according to the ID annotations. Three isotopic precursors (M+0,
M+1 and M+2) were extracted and summed for quantification. The
abundance of each targeted peptide was normalized by the relative
protein concentration, which was inferred by the label-free TOP3
Yen Lin of Instrumentation Center, National Taiwan University,
for the assistance in TEM experiments. We also thank the
valuable technical supports of Ms. Meng-Ting Wu and Mr. Kuan-
Chieh Peng (Department of Chemistry, National Taiwan
University) in MS experiments. We thank Dr. Mei-Chun Tseng in
the Institute of Chemistry, Academia Sinica, Taiwan, for ESI-MS
experiment and consultation with the analysis of intact protein.
Conflict of Interest
The authors declare no competing financial interest.
[
18]
method.
Specifically, the integration of three most intense unique
Keywords: Flagellin • toll-like receptor • site-selective
modification • conjugate vaccine • adjuvant • antigen
peptides, without any modification, were averaged and assumed to be
proportional to the relative protein concentration of each sample. The
data were presented as the relative abundance of identical azido-
modified peptides. The p values were determined by comparing the MS1
intensity of each identical peptide with Student’s t test (n = 5).
[
1] a) R. Adamo, Acc. Chem. Res. 2017, 50, 1270-1279; b) J. B. Robbins, R.
Schneerson, J. Infect. Dis. 1990, 161, 821-832.
[2] M. E. Pichichero, Hum. Vaccines Immunother. 2013, 9, 2505-2523.
[
3] a) M. J. McCluskie, D. M. Evans, N. Zhang, M. Benoit, S. P. McElhiney, M.
Unnithan, S. C. DeMarco, B. Clay, C. Huber, A. Deora, J. M. Thorn, D. R.
Stead, J. R. Merson, H. L. Davis, Immunopharmcol. immunotoxicol. 2016,
38, 184-196; b) M. P. Schutze, C. Leclerc, M. Jolivet, F. Audibert, L.
Chedid, J. Immunol. 1985, 135, 2319-2322.
Molecular Modeling of paFliC and Assignment of Azido-modification
Sites. The homologous sequence searches and alignment of flagellin
(
(
UniProt code P72151) were performed with Chimera software
https://www.cgl.ucsf.edu/chimera/), version 1.11.2, using a BLAST web
[
4] a) V. L. Campodonico, N. J. Llosa, M. Grout, G. Doring, T. Maira-Litran, G.
B. Pier, Infect. Immun. 2010, 78, 746-755; b) W. J. Landsperger, K. D.
Kelly-Wintenberg, T. C. Montie, L. S. Knight, M. B. Hansen, C. C.
Huntenburg, M. J. Schneidkraut, Infect. Immun. 1994, 62, 4825-4830.
service provided by NCBI and the RCSB PDB as a searching database.
The structural model of native paFliC was generated using Modeller
version 9.17 (San Francisco, CA, USA). The full-length flagellin (PDB
code 3A5X, chain A) derived from Salmonella enterica was used as the
homology template (39.5% ID). The protofilament structure of flagella
was simulated by two sequential steps. First, the axially stacked dimer
structure of paFliC was generated by using ClusPro web service version
[5] S. B. Mizel, J. T. Bates, J. Immunol. 2010, 185, 5677-5682.
[
6] R. Simon, J. Y. Wang, M. A. Boyd, M. E. Tulapurkar, G. Ramachandran,
S. M. Tennant, M. Pasetti, J. E. Galen, M. M. Levine, Plos One 2013, 8,
e64680.
[7] V. L. Campodonico, N. J. Llosa, L. V. Bentancor, T. Maira-Litran, G. B.
Pier, Infect. Immun. 2011, 79, 3455-3464.
[
[
8] a) A. Kimishima, C. J. Wenthur, L. M. Eubanks, S. Sato, K. D. Janda, Mol.
Pharmaceutics 2016, 13, 3884-3890; b) J. W. Lockner, L. M. Eubanks, J.
L. Choi, J. M. Lively, J. E. Schlosburg, K. C. Collins, D. Globisch, R. J.
Rosenfeld-Gunn, I. A. Wilson, K. D. Janda, Mol. Pharmaceutics 2015, 12,
653-662.
2
.0 (Boston University and Stony Brook University, USA), based on the
[
14b]
interactive amino acid residues as previously reported.
The simulation
of tubular structure of flagella was performed with SymmDock program
http://bioinfo3d.cs.tau.ac.il/SymmDock/) using stacked dimer as a block
with D0 domain as the binding site, and the symmetry order was set as
1. The circle construct of two proto-filaments obtained from SymmDock
server was manually adjusted to produce the helical structure, based on
(
9] a) F. Qian, A. Guo, M. Li, W. Liu, Z. Pan, L. Jiang, X. Wu, H. Xu, Vaccine
2015, 33, 2038-2044; b) H. Liu, D. J. Irvine, Bioconjugate Chem. 2015, 26,
1
791-801; c) M. Kreutz, B. Giquel, Q. Hu, R. Abuknesha, S. Uematsu, S.
Akira, F. O. Nestle, S. S. Diebold, Plos One 2012, 7, e40208; d) J. M.
Blander, R. Medzhitov, Nature 2006, 440, 808-812; e) T. Maurer, A. Heit,
H. Hochrein, F. Ampenberger, M. O'Keeffe, S. Bauer, G. B. Lipford, R. M.
Vabulas, H. Wagner, Eur. J. Immunol. 2002, 32, 2356-2364.
[
14a]
the atomic model of the flagellar filament as previously reported.
Evaluation of hTLR5 Activity. The capability of native paFliC, azido-,
and maltoside-modified paFliC to stimulate TLR5 was evaluated by a
SEAP reporter cellular assay using an HEK-Blue hTLR5 cell line
[
10] O. Boutureira, G. J. Bernardes, Chem. Rev. 2015, 115, 2174-2195.
[11] X. Chen, K. Muthoosamy, A. Pfisterer, B. Neumann, T. Weil, Bioconjugate
Chem. 2012, 23, 500-508.
[
12] a) B. V. Popp, Z. T. Ball, Chem. Sci. 2011, 2, 690-695; b) Z. T. Ball, Acc.
Chem. Res. 2013, 46, 560-570.
13] a) W. S. Song, Y. J. Jeon, B. Namgung, M. Hong, S. I. Yoon, Sci. Rep.
2017, 7, 40878; b) W. S. Song, S. I. Yoon, Biochem. Biophys. Res.
Commun. 2014, 444, 109-115; c) S. I. Yoon, O. Kurnasov, V. Natarajan,
M. Hong, A. V. Gudkov, A. L. Osterman, I. A. Wilson, Science 2012, 335,
(
InvivoGen). According to the protocol, the suspension of HEK-Blue
4
hTLR5 cells was prepared at a concentration of 1.4 × 10 cells/mL in the
HEK-Blue Detection medium. Then the cell suspension was added to a
[
96-well plate (180 μL/well, ~25,000 cells per well). The paFliC purchased
from InvivoGen was used as a positive control, and 1X PBS buffer was
used as a negative control. In the presence of different concentrations of
the indicated paFliC samples (100, 50, and 10 ng/mL), the cells were
859-864; d) K. D. Smith, E. Andersen-Nissen, F. Hayashi, K. Strobe, M. A.
Bergman, S. L. R. Barrett, B. T. Cookson, A. Aderem, Nat. Immunol. 2003,
4, 1247-1253.
o
[
[
14] a) K. Yonekura, S. Maki-Yonekura, K. Namba, Nature 2003, 424, 643-
incubated at 37 C for 24 h; then the TLR5 activation was evaluated by
650; b) F. A. Samatey, K. Imada, S. Nagashima, F. Vonderviszt, T.
the absorbance at 620 nm due to the SEAP-catalyzed hydrolysis of
substrate. The data were presented as mean ± standard deviation (n = 5).
The comparison of paired samples was performed by using Student’s t
test.
Kumasaka, M. Yamamoto, K. Namba, Nature 2001, 410, 331-337.
15] S. Crotti, H. Zhai, J. Zhou, M. Allan, D. Proietti, W. Pansegrau, Q. Y. Hu,
F. Berti, R. Adamo, Chembiochem 2014, 15, 836-843.
[16] U. Moginger, A. Resemann, C. E. Martin, S. Parameswarappa, S.
Govindan, E. C. Wamhoff, F. Broecker, D. Suckau, C. L. Pereira, C. Anish,
P. H. Seeberger, D. Kolarich, Sci. Rep. 2016, 6, 20488.
For internal use, please do not delete. Submitted_Manuscript
This article is protected by copyright. All rights reserved.